{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:12:32Z","timestamp":1777605152094,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Helsinki University Hospital"},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of the Finnish Anti-Tuberculosis Association"},{"name":"Finnish Cancer Foundation"},{"DOI":"10.13039\/501100003128","name":"Finnish Work Environment Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cllc.2020.05.020","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:42:26Z","timestamp":1590234146000},"page":"e633-e639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4364-2201","authenticated-orcid":false,"given":"Juuso","family":"Paajanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Ilonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapio","family":"Vehmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko I.","family":"M\u00e4yr\u00e4np\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Sutinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-3010","authenticated-orcid":false,"given":"Eeva","family":"Kettunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo A.","family":"Salo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjukka","family":"Myll\u00e4rniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2020.05.020_bib1","first-page":"449","article-title":"Biomarkers and prognostic factors for mesothelioma","volume":"1","author":"Pass","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2020.05.020_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A\u00a0nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cllc.2020.05.020_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2020.05.020_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2016.05.023","article-title":"Circulating epigenetic biomarkers in lung malignancies: from early diagnosis to therapy","volume":"107","author":"Tomasetti","year":"2017","journal-title":"Lung Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.cllc.2020.05.020_bib5","first-page":"S397","article-title":"Malignant pleural mesothelioma: current and future perspectives","volume":"5","author":"Porpodis","year":"2013","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.cllc.2020.05.020_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/JTO.0b013e3181ba2033","article-title":"Prognostic factors according to the treatment schedule in malignant pleural mesothelioma","volume":"4","author":"Ak","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib7","first-page":"63","article-title":"Modern management of malignant pleural mesothelioma","volume":"7","author":"Patel","year":"2016","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.cllc.2020.05.020_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5301\/JBM.2011.8614","article-title":"Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide","volume":"26","author":"Dipalma","year":"2011","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.cllc.2020.05.020_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib10","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib11","doi-asserted-by":"crossref","first-page":"w13686","DOI":"10.4414\/smw.2012.13686","article-title":"Long term survival after trimodal therapy in malignant pleural mesothelioma","volume":"142","author":"Fahrner","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.cllc.2020.05.020_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","article-title":"Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours","volume":"77","author":"Leinonen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2020.05.020_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gut.2004.047191","article-title":"Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry","volume":"54","author":"Carpelan-Holmstrom","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cllc.2020.05.020_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cllc.2020.05.020_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.001","article-title":"Computed tomography in the evaluation of malignant pleural mesothelioma - association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival","volume":"116","author":"Paajanen","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2020.05.020_bib17","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.cllc.2020.05.020_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajim.4700210205","article-title":"Fibrous minerals in the lungs of mesothelioma patients: comparison between data on SEM, TEM, and personal interview information","volume":"21","author":"Tuomi","year":"1992","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.cllc.2020.05.020_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/annonc\/mds535","article-title":"Disease volumes as a marker for patient response in malignant pleural mesothelioma","volume":"24","author":"Labby","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2020.05.020_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.12688\/f1000research.15512.2","article-title":"Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort","volume":"7","author":"Amin","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.cllc.2020.05.020_bib23","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2020.05.020_bib24","first-page":"1237","article-title":"Ionizing radiation: a risk factor for mesothelioma","volume":"20","author":"Goodman","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cllc.2020.05.020_bib25","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1200\/JCO.2013.49.9616","article-title":"Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma","volume":"31","author":"Chirieac","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib26","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib27","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","article-title":"Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies","volume":"41","author":"Remon","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cllc.2020.05.020_bib29","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.cllc.2020.05.020_bib30","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.cllc.2020.05.020_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.athoracsur.2015.04.087","article-title":"Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: a multicenter analysis","volume":"100","author":"Leuzzi","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2020.05.020_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"Ceresoli","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2020.05.020_bib33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","article-title":"Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems","volume":"55","author":"Edwards","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.cllc.2020.05.020_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1289\/ehp.11151","article-title":"Asbestos burden predicts survival in pleural mesothelioma","volume":"116","author":"Christensen","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.cllc.2020.05.020_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"R\u00f8e","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.cllc.2020.05.020_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamaoncol.2015.3113","article-title":"JAMA Oncology Patient Page. Performance status in patients with cancer","volume":"1","author":"West","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2020.05.020_bib37","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730420301601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730420301601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:10:23Z","timestamp":1761505823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730420301601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1525730420301601"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2020.05.020","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2020.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}